MAPT and neurodegenerative disease: While tau may not be a direct palmitoylation target, its pathological effects on axonal transport are strongly influenced by palmitoylation-dependent signaling and protein interactions, underscoring the importance of including tau in discussions of palmitoylation in neurodegenerative disease.